癌症治疗相关心脏功能障碍的发展与乳腺癌的疾病进展有关
Fumika Haga1, Masayoshi Oikawa1, Tetsuya Tani1
1Department of Cardiovascular Medicine, Fukushima Medical University Fukushima Japan.
Circulation reports
|February 11, 2026
概括
癌症治疗相关的心脏功能障碍 (CTRCD) 影响乳腺癌的生存率. 使用心脏素I (cTnI) 早期检测CTRCD对于心脏保护和改善癌症预后至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 心脏瘤学 - 心脏瘤学
背景情况:
- 癌症治疗相关的心脏功能障碍 (CTRCD) 是乳腺癌治疗的已知并发症.
- 建议通过心脏生物标志物如心脏托罗邦素I (cTnI) 进行早期检测,但其预后影响尚不清楚.
研究的目的:
- 研究CTRCD对接受心脏毒性治疗的乳腺癌患者癌症预后的影响.
- 评估CTRCD,心脏功能和癌症进展之间的关系.
主要方法:
- 对273名接受 antracycline 和/或 HER2 向治疗的乳腺癌患者进行前性观察性研究.
- 在24个月内对cTnI,BNP和LVEF进行连续测量.
- 根据LVEF下降定义的CTRCD;分为轻度,中度或严重.
主要成果:
- CTRCD发生在14.7%的患者中.
- 在患有升高cTnI的患者中,轻度CTRCD与较大的LVEF降低有关.
- CTRCD是癌症进展的独立预测因子 (HR2.50,P=0.018).
结论:
- CTRCD与乳腺癌患者的无进展生存率降低有关.
- 早期发现CTRCD对于心脏病管理和癌症预后至关重要.
- 强调心脏生物标志物在预测癌症结果中的作用.
相关概念视频
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer
54.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.5K
What is Cancer?
14.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K


